ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

INVO INVO BioScience Inc

0.92
-0.01 (-1.08%)
최종 업데이트: 00:54:46
15분 지연
기업명 주식 심볼 시장 주식 타입
INVO BioScience Inc INVO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.01 -1.08% 0.92 00:54:46
개장가 저가 고가 종가 전일 종가
0.95 0.90 0.9599 0.93
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
07/05/202406:30EDGAR2Form 8-K - Current report
17/04/202423:25APSMicro Cap Massively Bid Up Before Opening Bell
17/04/202405:59GLOBEINVO Reports Fourth Quarter and Full Year 2023 Financial..
07/02/202400:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/02/202423:01EDGAR2Form 8-K - Current report
23/01/202422:00GLOBENAYA Biosciences To Acquire Clinical Stage Gene Therapy..
17/01/202422:00GLOBEINVO Bioscience Files S-4 Registration and Preliminary Joint..
17/01/202407:29EDGAR2Form S-4 - Registration of securities, business combinations
11/01/202406:46EDGAR2Form 8-K/A - Current report: [Amend]
11/01/202406:05EDGAR2Form 8-K - Current report
04/01/202407:29EDGAR2Form 8-K - Current report
29/12/202307:04EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
29/12/202307:02EDGAR2Form 8-K - Current report
14/12/202307:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/12/202306:53EDGAR2Form 8-K - Current report
11/12/202322:00PRNUSNAYA Biosciences Announces Publication of New Data for its..
29/11/202307:18EDGAR2Form 8-K - Current report
28/11/202323:00PRNUSINVO Bioscience Regains Compliance with Nasdaq Minimum..
25/11/202303:08EDGAR2Form DEF 14A - Other definitive proxy statements
21/11/202306:59EDGAR2Form 8-K - Current report
14/11/202306:10EDGAR2Form 8-K - Current report
14/11/202306:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:01PRNUSINVO Reports Record Third Quarter 2023 Financial Results
13/11/202323:23EDGAR2Form SC TO-C - Written communication relating to an issuer..
13/11/202323:21EDGAR2Form 8-K - Current report
13/11/202323:12EDGAR2Form PRE 14A - Other preliminary proxy statements
10/11/202323:00PRNUSNAYA Biosciences and INVO Bioscience Announce Appointment of..
10/11/202306:40PRNUSINVO Bioscience Announces Commencement of Waiver..
27/10/202322:00PRNUSFree Registration Is Now Open For Tribe Public's CEO and Q&A..
27/10/202305:56EDGAR2Form 8-K - Current report
25/10/202306:10EDGAR2Form 8-K - Current report
23/10/202320:30PRNUSINVO Bioscience and NAYA Biosciences Announce Definitive..
16/10/202319:15EDGAR2Form 8-K - Current report
11/10/202322:00PRNUSINVO to Participate in the Lytham Partners Fall 2023..
06/10/202305:28EDGAR2Form 8-K - Current report
04/10/202306:24EDGAR2Form 8-K - Current report
03/10/202306:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/09/202306:26EDGAR2Form 8-K - Current report
30/09/202305:05PRNUSINVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF..
29/09/202301:45EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/09/202301:30PRNUSINVO Reminds Shareholders to Cast Their Vote for Upcoming..
09/09/202305:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/09/202306:17EDGAR2Form 8-K - Current report
01/09/202322:55EDGAR2Form DEF 14A - Other definitive proxy statements
22/08/202305:33EDGAR2Form PRE 14A - Other preliminary proxy statements
15/08/202305:10EDGAR2Form 8-K - Current report
15/08/202305:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/08/202305:05PRNUSINVO Reports Second Quarter 2023 Financial Results
12/08/202305:18EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/08/202303:07EDGAR2Form 8-K - Current report

최근 히스토리

Delayed Upgrade Clock